Cenobamate Shows Promise for Treating Epilepsy in Children
⚠️ Infant dosing/safety: medication and diet decisions for infants require individualized medical guidance.
Source: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Summary
A study was conducted to look at how cenobamate, a medication approved for adults with epilepsy, works in children with drug-resistant epilepsy. The researchers focused on 50 children, aged between 3 and 18 years, who had not found relief from their seizures with other treatments. They collected information on how well cenobamate worked, the dosages used, how long the children stayed on the medication, and any side effects they experienced.
The results showed that cenobamate was effective for many of the children. About 60% of the participants had a significant reduction in their seizures, and 12% were completely free of major motor seizures. Additionally, some children were able to stop taking other seizure medications while on cenobamate. Most children tolerated the medication well, but some experienced mild side effects like drowsiness, nausea, or coordination issues.
This study is important because it suggests that cenobamate can be a helpful option for children with difficult-to-treat epilepsy, similar to what has been seen in adults. However, it is worth noting that this study involved a small group of patients at just one center, so more research is needed to confirm these findings in larger and more diverse populations.
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.
